Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1983 Nov;18(5):1131–1137. doi: 10.1128/jcm.18.5.1131-1137.1983

Rubella antibodies detected by several commercial immunoassays in hemagglutination inhibition-negative sera.

K T Kleeman, D J Kiefer, S P Halbert
PMCID: PMC272855  PMID: 6643666

Abstract

Although a very good correlation was found between the level of rubella antibodies measured by a standard hemagglutination inhibition (HI) test and by an enzyme-linked immunosorbent assay (ELISA) procedure (Cordia R), an appreciable proportion (31%) of ELISA-positive specimens were encountered among HI-negative sera. The reverse was rarely seen. Many of the HI-negative, ELISA-positive sera were also found to be positive for rubella antibodies by one or more other assay methods, including an immunofluorescence assay (IFA) procedure (FIAX), passive hemagglutination (PHA) (Rubacell and PHAST), latex agglutination (Rubascan), and a second ELISA procedure (Rubelisa). The specificity of all of the ELISA-positive HI-negative specimens was substantiated by absorption experiments. In these tests, the ELISA reactivities were blocked by rubella antigens, but not by a variety of tissue culture control antigens or by influenza virus grown on the same cell line. The findings indicate that many of the newer methods available for rubella antibody detection are more sensitive than HI for detecting low levels of rubella antibodies. Until more clinical information is available concerning the protective nature of these low levels of antibody, caution should be exercised in assessing the significance of these results.

Full text

PDF
1131

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balfour H. H., Jr, Groth K. E., Edelman C. K., Amren D. P., Best J. M., Banatvala J. E. Rubella viraemia and antibody responses after rubella vaccination and reimmunization. Lancet. 1981 May 16;1(8229):1078–1080. doi: 10.1016/s0140-6736(81)92243-1. [DOI] [PubMed] [Google Scholar]
  2. Buimovici-Klein E., O'Beirne A. J., Millian S. J., Cooper L. Z. Low level rubella immunity detected by ELISA and specific lymphocyte transformation. Arch Virol. 1980;66(4):321–327. doi: 10.1007/BF01320628. [DOI] [PubMed] [Google Scholar]
  3. Halonen P. E., Stewart J. A., Hall A. D. Rubella hemagglutinin prepared in serum free suspension culture of BHK-21 cells. Ann Med Exp Biol Fenn. 1967;45(2):182–185. [PubMed] [Google Scholar]
  4. Leinikki P. O., Shekarchi I., Dorsett P., Sever J. L. Enzyme-linked immunosorbent assay determination of specific rubella antibody levels in micrograms of immunoglobulin G per milliliter of serum in clinical samples. J Clin Microbiol. 1978 Oct;8(4):419–423. doi: 10.1128/jcm.8.4.419-423.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Meegan J. M., Evans B. K., Horstmann D. M. Comparison of the latex agglutination test with the hemagglutination inhibition test, enzyme-linked immunosorbent assay, and neutralization test for detection of antibodies to rubella virus. J Clin Microbiol. 1982 Oct;16(4):644–649. doi: 10.1128/jcm.16.4.644-649.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Morgan-Capner P., Pullen H. J., Pattison J. R., Bidwell D. E., Bartlett A., Voller A. A comparison of three tests for rubella antibody screening. J Clin Pathol. 1979 Jun;32(6):542–545. doi: 10.1136/jcp.32.6.542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. NORRBY E. Hemagglutination by measles virus. 4. A simple procedure for production of high potency antigen for hemagglutination-inhibition (HI) tests. Proc Soc Exp Biol Med. 1962 Dec;111:814–818. doi: 10.3181/00379727-111-27930. [DOI] [PubMed] [Google Scholar]
  8. Scott R. M., Schydlower M., Lampe R. M., Schwab J. A., Muelenaer A. A., Jr The immunoglobulin response to reimmunization with rubella vaccine. J Pediatr. 1981 Oct;99(4):531–534. [PubMed] [Google Scholar]
  9. Stewart G. L., Parkman P. D., Hopps H. E., Douglas R. D., Hamilton J. P., Meyer H. M., Jr Rubella-virus hemagglutination-inhibition test. N Engl J Med. 1967 Mar 9;276(10):554–557. doi: 10.1056/NEJM196703092761006. [DOI] [PubMed] [Google Scholar]
  10. TARTAKOW I. J. THE TERATOGENICITY OF MATERNAL RUBELLA. J Pediatr. 1965 Feb;66:380–391. doi: 10.1016/s0022-3476(65)80196-2. [DOI] [PubMed] [Google Scholar]
  11. Vejtorp M. Enzyme-linked immunosorbent assay for determination of rubella IgG antibodies. Acta Pathol Microbiol Scand B. 1978 Dec;86B(6):387–392. doi: 10.1111/j.1699-0463.1978.tb00061.x. [DOI] [PubMed] [Google Scholar]
  12. Vejtorp M., Leerhoy J. Comparison of the sensitivity of ELISA and the haemagglutination-inhibition test for routine diagnosis of rubella. Acta Pathol Microbiol Scand B. 1980 Dec;88(6):349–350. doi: 10.1111/j.1699-0463.1980.tb02655.x. [DOI] [PubMed] [Google Scholar]
  13. Weissfeld A. S., Gehle W. D., Sonnenwirth A. C. Comparison of several test systems used for determination of rubella immune status. J Clin Microbiol. 1982 Jul;16(1):82–85. doi: 10.1128/jcm.16.1.82-85.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES